N-Acetylcysteine Amide not checked

Nacuity Pharmaceuticals, Inc. · NPI-001

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
2 active
4 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“N-acetylcysteine amide (NPI-001) tablets (250 mg), taken BID”In the company’s words, NCT07290530 on ClinicalTrials.gov
Tested for
Retinitis Pigmentosa (RP) (2 trials), Usher Syndrome (2 trials)
Main trialPhase 3
“The goal of this clinical trial is to learn if NPI-001 works to prevent progression of retinitis pigmentosa in adults diagnosed with Usher syndrome. It will also provide information about the safety of NPI-001. The main questions it aims to answer are: Does NPI-001 slow down the loss of photoreceptors? What medical problems do participants have when taking NPI-001? Researchers will compare NPI-001 to a placebo (a look-alike substance that contains no drug) to see if NPI-001 works to preserve vision. Participants will: Take NPI-001 or a placebo twice a day, every day for 24 months and visit…”In the company’s words, NCT07710196 on ClinicalTrials.gov
Other names
NPI-001

Other drugs for Retinitis Pigmentosa (RP)

All 4 drugs for Retinitis Pigmentosa (RP)

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 3Recruiting Apr 2029 A 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome
Phase 3Not yet recruiting Jul 2029 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome
Phase 1/2Completed 20 Jun 2025 Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome
Phase 1/2Completed 26 May 2026 PK and PD Study of NPI-001 and Cysteamine Bitartrate
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow N-Acetylcysteine Amide

Following is part of Solo: you see every change to N-Acetylcysteine Amide the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in